CD4 and neurocutaneous melanocytosis: At baseline, CD4+ T cells were higher among subjects with NCM (median, 13.6%; IQR, 1%–6%) compared with the CM group (median, 3.5%; IQR, 5%–29%; P = .01), whereas NK cells were present at comparable frequencies in patients with or without CM.